Complexities of plasma apolipoprotein C-III metabolism: Fig. 1.

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

(2011) Esther M. M. Ooi et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein CIII Induces Monocyte Chemoattractant Protein-1 and Interleukin 6 Expression Via Toll-Like Receptor 2 Pathway in Mouse Adipocytes: Retracted

(2010) Yasuko Abe et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

Functional analysis of the missenseAPOC3mutation Ala23Thr associated with human hypotriglyceridemia

(2010) Meenakshi Sundaram et al.   JOURNAL OF LIPID RESEARCH

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

(2009) A. Hiukka et al.   DIABETES

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

(2009) M. Sundaram et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction

(2008) Akio Kawakami et al.   CIRCULATION

Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density Lipoprotein Apolipoprotein B and High-Density Lipoprotein Apolipoprotein A-I Metabolism

(2007) Dick C. Chan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM